In February 2009, Baxter’s Austrian subsidiary in Orth an der Donau manufactured and distributed 72 kilos of
vaccine material, contaminated with a H1N1 virus,
to 16 laboratories in four countries, including Austria, so nearly triggering a pandemic, according to The Times of India.
The contaminated vaccine material consisted of a mixture of a seasonal H3N2 human influenza virus and the deadly H5N1 virus.
By adding a virus of the type H5N1 to an ordinary flu virus of the type H3N2, Baxter produced a highly dangerous bioweapon. WHO supplied Baxter with the live bird flu virus. A staff member of a subcontracted laboratory in the Czech Republic discovered this lethal contamination, when all animals they tested died from this vaccine.
Since Baxter is obliged to use BSL 3 (Biosafety Level 3) precautions in its laboratories when handling the H1N1 virus (classified as a biological agent, BSL3 or 4 under EU regulations), such safeguards are in place as would make accidental contamination of ordinary influenza material with the dangerous H1N1 virus impossible.